EDN1 and Alzheimer disease: We previously showed the level of ET1 to be significantly raised in the temporal cortex in patients with Alzheimer’s disease compared with control subjects (Palmer et al., 2012), probably in response to amyloid-β accumulation, as evidenced by in vitro studies (Palmer et al., 2013).